Safe Chemotherapy Infusion

Care and Hope. Infused. ™

Unique Methods and Technology

Save lives, reduce risks and injuries

About Swiss Medendi

Swiss Medendi is a medical device company based in Lugano, Switzerland. Swiss Medendi developed an exclusive infusion technology and produce medical devices which improves the quality of life for those patients receiving infusions of vesicant and irritant drugs such as chemotherapeutics. The company is currently focused on Adjuvant Brest Cancer infusion therapy, but also develops devices for other cancer pathologies. Swiss Medendi goal is to provide a safe and cost convenient infusion therapy which reduces risks and injuries to all patients in need of vesicant and irritant drugs infusions

Vascular damage

Vascular damage induced by ions and cytotoxic drugs are frequent events and known as chemical phlebitis

Loss of endothelial cells
Inflammatory cells infiltration
Edema
Thrombosis
Sclerosis

Injuries can be proximal or distal to the catheter tips and usually irritates the venous endothelial cells over a longer distance from the catheter tip

Intellectual Property

Patents Granted.

Devices

All our devices are disposable and of class IIa. Those do not vary therapeutics administration protocols, infusion speed or drug concentration.
Employing the technology will help hospitals to manage costs, enable doctors to focus more on their patients’ needs, and improve patients’ quality of life.

Unique Methods and Technology

Swiss Medendi owns unique technology able to protect patients’ veins from vesicant agents causing irreversible endothelial damages, saving lives, reducing risks and injuries offering enormous cost saving.